Insmed

About Insmed

Insmed Inc is a biopharmaceutical company focused on developing and commercializing therapies for patients with serious and rare diseases. Its portfolio includes ARIKAYCE for refractory nontuberculous mycobacterial lung infections, and a pipeline of drug candidates in clinical trials for conditions such as bronchiectasis, chronic rhinosinusitis, hidradenitis suppurativa, pulmonary hypertension associated with interstitial lung disease, and Duchenne muscular dystrophy. Insmed operates internationally, with a commitment to innovative drug development and a patient-first approach.